Mansat-De Mas Véronique, Rigal-Huguet Françoise, Cassar Georges, Kuhlein Emilienne, Laurent Guy, Dastugue Nicole
Laboratoire d'Hématologie, Pavillon Caubet, Centre Hospitalier, Universitaire Purpan, Place du Dr Baylac, 31059 Toulouse, France.
Leuk Lymphoma. 2003 May;44(5):867-9. doi: 10.1080/1042819031000063435.
The simultaneous occurrence of Philadelphia positive chronic myeloid leukemia (Ph+ CML) and B-cell chronic lymphocytic leukemia (B-CLL) is a rare event which raises the possibility that the two malignant clones derive from a common, or distinct, malignant stem cells. In this study, we used combined CD19-based cell-sorting and fluorescence in situ hybridisation (FISH) to investigate whether or not the BCR-ABL fusion gene was present in the malignant B-cells of a patient who presented a Ph+ CML/B-CLL association. The CD19+ cells lacked the BCR-ABL rearrangement whereas all CD19-cells exhibited the fusion gene. This result demonstrates that B-cell transformation occurred in a Ph-B-cell subset.